Treatment of severe pulmonary hypertension with prostacyclin and its analogue iloprost

被引：2
|
作者：
Matthes, J
Mathen, F
Herzig, S
Wassermann, K
机构：
[1] Univ Cologne, Innere Med Klin 3, Arbeitsgrp Pneumol, D-50922 Cologne, Germany
[2] Univ Cologne, Inst Pharmakol, D-50922 Cologne, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2001年 / 126卷 / 21期
关键词：
D O I：
10.1055/s-2001-14422
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：631 / 637
页数：7
相关论文
共 50 条
  • [31] Sustained Improvement With Iloprost in a COPD Patient With Severe Pulmonary Hypertension
    Hegewald, Matthew J.
    Elliott, C. Gregory
    CHEST, 2009, 135 (02) : 536 - 537
  • [32] Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension.
    Caneva, JO
    Osses, JM
    MEDICINA-BUENOS AIRES, 2003, 63 (03) : 233 - 236
  • [33] Combination of inhaled nitric oxide with iv nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension
    VanObbergh, LJ
    Charbonneau, M
    Blaise, G
    BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (02) : 227 - 231
  • [34] Inhaled iloprost in pulmonary hypertension and severe respiratory failure in childhood
    Ehlen, M
    Esser, R
    Kipping, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2003, 151 (05) : 539 - 543
  • [35] Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension
    Gessler, T
    Schmehl, T
    Hoeper, MM
    Rose, F
    Ghofrani, HA
    Olschewski, H
    Grimminger, F
    Seeger, W
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (01) : 14 - 19
  • [36] Use of prostacyclin and prostacyclin-analogues in the treatment of pulmonary hypertension
    Ghofrani, H. A.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 12 - 12
  • [37] Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension
    Reichenberger, F.
    Mainwood, A.
    Doughty, N.
    Fineberg, A.
    Morrell, N. W.
    Pepke-Zaba, J.
    RESPIRATORY MEDICINE, 2007, 101 (02) : 217 - 222
  • [38] Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia
    Boccalon, H
    Braga, A
    Breddin, K
    Catalano, H
    Dormandy, J
    Norgren, L
    Lopaciuk, S
    Andreassian, A
    Lesèche, G
    Balzer, K
    Belch, J
    Bergqvist, D
    Bielawiec, M
    Bliss, B
    Wilkins, DC
    Björk, CS
    Boccalon, H
    Boissier, C
    Braga, A
    Breddin, K
    Brunkwall, J
    Catalano, M
    Chester, J
    Cucinotta, D
    Diehm, C
    Enon, B
    Fiessinger, JN
    Giansante, C
    Guilrnot, JL
    Imbs, J
    Jernby, B
    Juhan, C
    Karlqvist, PA
    Kester, R
    Krzanowski, M
    Larroque, P
    Lepäntalo, M
    Loose, D
    Mannarino, E
    Mátyás, L
    McFarland, R
    Meissner, A
    Michalak, J
    Moricke, R
    Myhre, H
    Norgren, L
    Pagnan, A
    Parsson, H
    Pereira, E
    Qvarfordt, P
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (04) : 358 - 362
  • [39] Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension
    Ichida, F
    Uese, KI
    Hamamichi, Y
    Hashimoto, I
    Tsubata, SI
    Fukahara, K
    Murakami, A
    Miyawaki, T
    ACTA PAEDIATRICA JAPONICA, 1998, 40 (01): : 14 - 19
  • [40] Iloprost inhalation solution for the treatment of pulmonary arterial hypertension
    Hsu, HH
    Rubin, LJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (11) : 1921 - 1930
12345